Review
Open access
Aug 2026
Beta-Blocker Discontinuation in Heart Failure with Preserved or Improved Ejection Fraction: A Systematic Review.
In HFpEF, beta-blocker discontinuation improved functional capacity and quality-of-life at 2 weeks compared with continuation with no clear effect on cognition, echocardiographic parameters or CV biomarkers, but findings on important long-term clinical outcomes was conflicting.
Wade Thompson, Nima Alaeiilkhchi, Lisa M. McCarthy et al.
· Journal of Cardiac Failure · 0 citations